Tag - medicine

 
 

MEDICINE

Japan Times
WORLD / Science & Health
Oct 19, 2021
What scientists know about the risk of breakthrough COVID-19 deaths
After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 14, 2021
Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
Japan Times
WORLD / FOCUS
Oct 13, 2021
Why some nations using the same vaccines have deadlier COVID-19 outbreaks
Everything from dose intervals to the behavior of unvaccinated people has shaped the outcome of recent delta-driven waves in different countries.
Japan Times
WORLD
Oct 11, 2021
AstraZeneca drug effective at treating mild COVID-19 symptoms in trial
The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
BUSINESS / Companies
Oct 8, 2021
COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says
Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.
Japan Times
WORLD / Science & Health / FOCUS
Oct 7, 2021
A Chilean tree holds hope for new vaccines — if supplies last
Quillay trees, technically known as Quillaja saponaria, are rare evergreens native to Chile that have long been used by the indigenous Mapuche people to make soap and medicine.
Japan Times
WORLD / Science & Health
Oct 7, 2021
In major breakthrough, WHO backs malaria vaccine rollout for Africa's children
The WHO says 94% of malaria cases and deaths occur in Africa, a continent of 1.3 billion people.
Japan Times
COMMENTARY / Japan
Oct 3, 2021
How Japan’s new PM can take a lead in improving global health
Prime Minister Suga's successor has a chance at becoming a global leader by helping end COVID-19 elsewhere in the world — a move that could also see Japan advance its foreign policy goals.
JAPAN
Oct 2, 2021
Japan urges prefectures to beef up medical systems ahead of winter virus wave
The health ministry has called for expanding the number of available beds nationwide on the assumption that the next wave of the virus could be at least as bad as this summer's fifth wave.
Japan Times
WORLD / FOCUS
Oct 2, 2021
Nobel Prize in medicine for COVID-19 vaccine? It may be too soon.
Among those seen by other scientists as potential winners are Hungarian-born Katalin Kariko and American Drew Weissman for their work on what are known as messenger ribonucleic acid (mRNA) vaccines.
Japan Times
WORLD / Science & Health
Oct 2, 2021
Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths
An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.
Japan Times
COMMENTARY / World
Sep 30, 2021
Singapore's lauded COVID-19 response overlooked a major factor: fear
Singapore's case count is low by global standards, but a recent spike is staggering for a country that had all but eliminated COVID-19 before the delta variant emerged.
Japan Times
COMMENTARY / World
Sep 29, 2021
Liars may get COVID-19 boosters before those in need
Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.
Japan Times
JAPAN / Science & Health
Sep 27, 2021
Japan approves second drug for mildly ill COVID-19 patients
Sotrovimab was given the green light three weeks after GlaxoSmithKline's Japan unit submitted its application for the antibody treatment to the health ministry.

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.